Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 100 Pages
Report ld: 4407029
Request Sample
Customized Report
Urolithin A Market Size(US$)

CAGR 2025-2031
6.1%
Market Size,2031
USD 59.3
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Urolithin A was valued at US$ 39.4 million in the year 2024 and is projected to reach a revised size of US$ 59.3 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Urolithin A is a natural compound with multiple biological activities. It is a yellow or light yellow solid powder at room temperature and pressure. It can be dissolved in highly polar organic solvents such as dimethyl sulfoxide and N,N-dimethylformamide, but has poor solubility in low-polar petroleum ether and ether, and also has poor solubility in water.
Urolithin A is a secondary metabolite of the natural polyphenol compound ellagitannin metabolized by intestinal microorganisms, and is also an intestinal microbial metabolite of ellagic acid. After the human body ingests ellagitannin and ellagic acid, urolithin A is metabolized by intestinal flora.
Urolithin A can inhibit the activity of nuclear factor κB (NF-κB), reduce the production of inflammatory factors, and thus reduce inflammatory damage. As a mitochondrial autophagy inducer, urolithin A can prevent muscle aging and promote cell health, thereby playing an anti-aging role. It can also inhibit the activity of telomerase and delay cell aging. Urolithin A can scavenge free radicals in the body, protect cells from oxidative damage, and maintain the normal physiological functions of the body. It can also bind to peroxisome proliferator-activated receptor γ (PPARγ) and activate the PPARγ signaling pathway, thereby enhancing the antioxidant capacity of cells.
With the improvement of people's living standards and the enhancement of health awareness, the demand for natural compounds with health functions continues to increase. Urolithin A, as a natural compound with multiple biological activities such as anti-inflammatory, anti-aging, and antioxidant, meets this market demand.
In recent years, scientific research on urolithin A has continued to deepen, revealing more of its biological activities and health benefits. These research results provide a solid theoretical basis for the application of urolithin A and promote the development of its market.
The continuous advancement of preparation technology, especially the research and development and application of new preparation processes such as biofermentation, has improved the preparation efficiency and purity of urolithin A, reduced production costs, and provided technical support for its wide application.
Urolithin A has broad application prospects in many fields such as dietary supplements, cosmetics, medicines, and health products. This wide range of application areas provides broad space for the market development of urolithin A.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Urolithin A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urolithin A.
The Urolithin A market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urolithin A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urolithin A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urolithin A manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Urolithin A by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Urolithin A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Urolithin A Market Overview
1.1 Product Definition
1.2 Urolithin A by Type
1.2.1 Global Urolithin A Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity: >98%
1.2.3 Purity: >99%
1.2.4 Others
1.3 Urolithin A by Application
1.3.1 Global Urolithin A Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Food Additives
1.3.3 Cosmetics
1.3.4 Drugs and Supplements
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Urolithin A Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Urolithin A Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Urolithin A Production Estimates and Forecasts (2020-2031)
1.4.4 Global Urolithin A Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Urolithin A Production Market Share by Manufacturers (2020-2025)
2.2 Global Urolithin A Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Urolithin A, Industry Ranking, 2023 VS 2024
2.4 Global Urolithin A Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Urolithin A Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Urolithin A, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Urolithin A, Product Offered and Application
2.8 Global Key Manufacturers of Urolithin A, Date of Enter into This Industry
2.9 Urolithin A Market Competitive Situation and Trends
2.9.1 Urolithin A Market Concentration Rate
2.9.2 Global 5 and 10 Largest Urolithin A Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Urolithin A Production by Region
3.1 Global Urolithin A Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Urolithin A Production Value by Region (2020-2031)
3.2.1 Global Urolithin A Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Urolithin A by Region (2026-2031)
3.3 Global Urolithin A Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Urolithin A Production Volume by Region (2020-2031)
3.4.1 Global Urolithin A Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Urolithin A by Region (2026-2031)
3.5 Global Urolithin A Market Price Analysis by Region (2020-2025)
3.6 Global Urolithin A Production and Value, Year-over-Year Growth
3.6.1 North America Urolithin A Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Urolithin A Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Urolithin A Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Urolithin A Production Value Estimates and Forecasts (2020-2031)
4 Urolithin A Consumption by Region
4.1 Global Urolithin A Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Urolithin A Consumption by Region (2020-2031)
4.2.1 Global Urolithin A Consumption by Region (2020-2025)
4.2.2 Global Urolithin A Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Urolithin A Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Urolithin A Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Urolithin A Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Urolithin A Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Urolithin A Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Urolithin A Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Urolithin A Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Urolithin A Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Urolithin A Production by Type (2020-2031)
5.1.1 Global Urolithin A Production by Type (2020-2025)
5.1.2 Global Urolithin A Production by Type (2026-2031)
5.1.3 Global Urolithin A Production Market Share by Type (2020-2031)
5.2 Global Urolithin A Production Value by Type (2020-2031)
5.2.1 Global Urolithin A Production Value by Type (2020-2025)
5.2.2 Global Urolithin A Production Value by Type (2026-2031)
5.2.3 Global Urolithin A Production Value Market Share by Type (2020-2031)
5.3 Global Urolithin A Price by Type (2020-2031)
6 Segment by Application
6.1 Global Urolithin A Production by Application (2020-2031)
6.1.1 Global Urolithin A Production by Application (2020-2025)
6.1.2 Global Urolithin A Production by Application (2026-2031)
6.1.3 Global Urolithin A Production Market Share by Application (2020-2031)
6.2 Global Urolithin A Production Value by Application (2020-2031)
6.2.1 Global Urolithin A Production Value by Application (2020-2025)
6.2.2 Global Urolithin A Production Value by Application (2026-2031)
6.2.3 Global Urolithin A Production Value Market Share by Application (2020-2031)
6.3 Global Urolithin A Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Daicel
7.1.1 Daicel Urolithin A Company Information
7.1.2 Daicel Urolithin A Product Portfolio
7.1.3 Daicel Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Daicel Main Business and Markets Served
7.1.5 Daicel Recent Developments/Updates
7.2 Suzhou Myland Pharm & Nutrition Inc.
7.2.1 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Company Information
7.2.2 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Product Portfolio
7.2.3 Suzhou Myland Pharm & Nutrition Inc. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Suzhou Myland Pharm & Nutrition Inc. Main Business and Markets Served
7.2.5 Suzhou Myland Pharm & Nutrition Inc. Recent Developments/Updates
7.3 Shenzhen Hygieia Biotech Co., Ltd
7.3.1 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Company Information
7.3.2 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Product Portfolio
7.3.3 Shenzhen Hygieia Biotech Co., Ltd Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shenzhen Hygieia Biotech Co., Ltd Main Business and Markets Served
7.3.5 Shenzhen Hygieia Biotech Co., Ltd Recent Developments/Updates
7.4 Wuhan Senwayer Century Chemical Co.,Ltd
7.4.1 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Company Information
7.4.2 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Product Portfolio
7.4.3 Wuhan Senwayer Century Chemical Co.,Ltd Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Wuhan Senwayer Century Chemical Co.,Ltd Main Business and Markets Served
7.4.5 Wuhan Senwayer Century Chemical Co.,Ltd Recent Developments/Updates
7.5 Henan Chenli Biotechnology Co., LTD.
7.5.1 Henan Chenli Biotechnology Co., LTD. Urolithin A Company Information
7.5.2 Henan Chenli Biotechnology Co., LTD. Urolithin A Product Portfolio
7.5.3 Henan Chenli Biotechnology Co., LTD. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Henan Chenli Biotechnology Co., LTD. Main Business and Markets Served
7.5.5 Henan Chenli Biotechnology Co., LTD. Recent Developments/Updates
7.6 Wuhan Hengheda Pharm Co., Ltd
7.6.1 Wuhan Hengheda Pharm Co., Ltd Urolithin A Company Information
7.6.2 Wuhan Hengheda Pharm Co., Ltd Urolithin A Product Portfolio
7.6.3 Wuhan Hengheda Pharm Co., Ltd Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Wuhan Hengheda Pharm Co., Ltd Main Business and Markets Served
7.6.5 Wuhan Hengheda Pharm Co., Ltd Recent Developments/Updates
7.7 Shenyang Hongjiuzhou Chemical Co., Ltd.
7.7.1 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Company Information
7.7.2 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Product Portfolio
7.7.3 Shenyang Hongjiuzhou Chemical Co., Ltd. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Shenyang Hongjiuzhou Chemical Co., Ltd. Main Business and Markets Served
7.7.5 Shenyang Hongjiuzhou Chemical Co., Ltd. Recent Developments/Updates
7.8 Shandong Airuike Chemical Co., Ltd.
7.8.1 Shandong Airuike Chemical Co., Ltd. Urolithin A Company Information
7.8.2 Shandong Airuike Chemical Co., Ltd. Urolithin A Product Portfolio
7.8.3 Shandong Airuike Chemical Co., Ltd. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Shandong Airuike Chemical Co., Ltd. Main Business and Markets Served
7.8.5 Shandong Airuike Chemical Co., Ltd. Recent Developments/Updates
7.9 LEADER BIOCHEMICAL GROUP
7.9.1 LEADER BIOCHEMICAL GROUP Urolithin A Company Information
7.9.2 LEADER BIOCHEMICAL GROUP Urolithin A Product Portfolio
7.9.3 LEADER BIOCHEMICAL GROUP Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.9.4 LEADER BIOCHEMICAL GROUP Main Business and Markets Served
7.9.5 LEADER BIOCHEMICAL GROUP Recent Developments/Updates
7.10 Cofttek
7.10.1 Cofttek Urolithin A Company Information
7.10.2 Cofttek Urolithin A Product Portfolio
7.10.3 Cofttek Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Cofttek Main Business and Markets Served
7.10.5 Cofttek Recent Developments/Updates
7.11 Fengchen Group Co.,Ltd
7.11.1 Fengchen Group Co.,Ltd Urolithin A Company Information
7.11.2 Fengchen Group Co.,Ltd Urolithin A Product Portfolio
7.11.3 Fengchen Group Co.,Ltd Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Fengchen Group Co.,Ltd Main Business and Markets Served
7.11.5 Fengchen Group Co.,Ltd Recent Developments/Updates
7.12 Natural Micron Chem Tech Co., Ltd.
7.12.1 Natural Micron Chem Tech Co., Ltd. Urolithin A Company Information
7.12.2 Natural Micron Chem Tech Co., Ltd. Urolithin A Product Portfolio
7.12.3 Natural Micron Chem Tech Co., Ltd. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Natural Micron Chem Tech Co., Ltd. Main Business and Markets Served
7.12.5 Natural Micron Chem Tech Co., Ltd. Recent Developments/Updates
7.13 Dalian Handom Chemicals Co.,Ltd
7.13.1 Dalian Handom Chemicals Co.,Ltd Urolithin A Company Information
7.13.2 Dalian Handom Chemicals Co.,Ltd Urolithin A Product Portfolio
7.13.3 Dalian Handom Chemicals Co.,Ltd Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Dalian Handom Chemicals Co.,Ltd Main Business and Markets Served
7.13.5 Dalian Handom Chemicals Co.,Ltd Recent Developments/Updates
7.14 Shaanxi LonierHerb Bio-Technology Co., Ltd.
7.14.1 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Company Information
7.14.2 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Product Portfolio
7.14.3 Shaanxi LonierHerb Bio-Technology Co., Ltd. Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Shaanxi LonierHerb Bio-Technology Co., Ltd. Main Business and Markets Served
7.14.5 Shaanxi LonierHerb Bio-Technology Co., Ltd. Recent Developments/Updates
7.15 Aktin Chemicals
7.15.1 Aktin Chemicals Urolithin A Company Information
7.15.2 Aktin Chemicals Urolithin A Product Portfolio
7.15.3 Aktin Chemicals Urolithin A Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Aktin Chemicals Main Business and Markets Served
7.15.5 Aktin Chemicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Urolithin A Industry Chain Analysis
8.2 Urolithin A Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Urolithin A Production Mode & Process Analysis
8.4 Urolithin A Sales and Marketing
8.4.1 Urolithin A Sales Channels
8.4.2 Urolithin A Distributors
8.5 Urolithin A Customer Analysis
9 Urolithin A Market Dynamics
9.1 Urolithin A Industry Trends
9.2 Urolithin A Market Drivers
9.3 Urolithin A Market Challenges
9.4 Urolithin A Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 160
USD 4900.00
(Single User License)
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 111
USD 3950.00
(Single User License)
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 144
USD 2900.00
(Single User License)
The global Urolithin A market is projected to grow from US$ 39.4 million in 2024 to US$ 59.3 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 4250.00
(Single User License)
The global market for Urolithin A was estimated to be worth US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 115
USD 3950.00
(Single User License)
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published Date: 2025-03-03
Pages: 151
USD 4900.00
(Single User License)
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 97
USD 2900.00
(Single User License)
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published Date: 2024-09-11
Pages: 124
USD 4350.00
(Single User License)
The global Urolithin A market is projected to grow from US$ 41.56 million in 2025 to US$ 62.54 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 160
The global Urolithin A market size was US$ 41.56 million in 2025 and is forecast to reach a readjusted size of US$ 62.54 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
The global market for Urolithin A was estimated to be worth US$ 41.56 million in 2025 and is projected to reach US$ 62.54 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 111
The global Urolithin A market was valued at US$ 41.56 million in 2025 and is anticipated to reach US$ 62.54 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-01-09
Pages: 144
The global Urolithin A market is projected to grow from US$ 39.4 million in 2024 to US$ 59.3 million by 2031, at a CAGR of 6.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 158
The global Urolithin A market size was US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
The global market for Urolithin A was estimated to be worth US$ 39.4 million in 2024 and is forecast to a readjusted size of US$ 59.3 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 115
Valued at US$ 41.6 million in 2024, the global Urolithin A market is forecast to reach US$ 59.3 million by 2030, at a CAGR of 6.1% during the forecast period.
Published: 2025-03-03
Pages: 151
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 97
Urolithin A is a gut microbiome-derived metabolite obtained through the fermentation of pomegranate polyphenols such as ellagic acid and ellagitannins. It is a compound that promotes mitochondrial health and ATP production for healthier ageing and longevity.
Published: 2024-09-11
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now